Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D  New England Journal of Medicine. 2024;391(2):133-143
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38842520

Chronic Rectal Schistosomiasis  New England Journal of Medicine. 2024;391(2):166
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38986060

Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial  Journal of Internal Medicine. 2024;296(2):187-199
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38845164

Colorectal cancer  Lancet. 2024;404(10449):294-310
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38909621

Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study  American Journal of Medicine. 2024;137(8):742-750.e11
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38641192

Correlation between Pancreatic Fat Deposition and Metabolic Syndrome: Relationships with Location in the Pancreas and Sex  Internal Medicine. 2024;63(15):2113-2123
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38171856

Diagnosis and Management of Celiac Disease  JAMA. 2024;332(3):249-250
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38922595

Dual Agonists for Management of Metabolic Dysfunction-Associated Steatohepatitis  New England Journal of Medicine. 2024;391(4):371-372
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39047246

Estimating the economic effect of harm associated with high risk prescribing of oral non-steroidal anti-inflammatory drugs in England: population based cohort and economic modelling study  BMJ. 2024;386:e077880
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39048136

Hepatologist Consultation in Low-Risk MASLD  New England Journal of Medicine. 2024;391(4):373-375
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39047247

Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation  New England Journal of Medicine. 2024;391(3):275-277
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39018537

Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab  Internal Medicine. 2024;63(15):2193-2198
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38171860

Lowering Fecal Immunochemical Test Positivity Threshold vs Multitarget Stool RNA Testing for Colorectal Cancer Screening  JAMA. 2024;332(3):251-252
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38823003

Making the best use of quantitative fecal immunochemical test results in colorectal cancer screening  Journal of Internal Medicine. 2024;296(2):118-120
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38894589

Pathogenesis and Management of Citrin Deficiency  Internal Medicine. 2024;63(14):1977-1986
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37952953

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD  Journal of Internal Medicine. 2024;296(2):177-186
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38959258

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis  New England Journal of Medicine. 2024;391(4):311-319
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38847460

Responses to systemic and topical glucocorticoids in coeliac crisis  Internal Medicine Journal. 2024;54(7):1239-1240
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39013771

Rethinking Drug-Induced Liver Injury-A New Era of Pharmacovigilance  JAMA Intern Med. 2024;184(8):952-953
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38913358

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease  New England Journal of Medicine. 2024;391(3):213-223
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39018531

The role of long noncoding RNA MEG3 in fibrosis diseases  Postgraduate Medical Journal. 2024;100(1186):529-538
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38430191

Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data  JAMA Intern Med. 2024;184(8):943-952
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38913369

Sotorasib in KRAS-Mutated Colorectal Cancer  New England Journal of Medicine. 2024;391(2):186-187
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38986067

Sotorasib in KRAS-Mutated Colorectal Cancer. Reply  New England Journal of Medicine. 2024;391(2):187
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38986068

Takotsubo cardiomyopathy in a patient with Lynch syndrome  Lancet. 2024;404(10449):276
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=39033011

Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis  New England Journal of Medicine. 2024;391(4):299-310
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38856224

Treatment of Hepatitis D - A Future Role for Combination Therapy  New England Journal of Medicine. 2024;391(2):181-183
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38842503

What Is Lynch Syndrome?  JAMA. 2024;332(2):178
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38823004